Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition

  • Ata F
  • Magboul H
  • Toba H
  • et al.
N/ACitations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Rifampicin is a bactericidal drug used in various infectious diseases, including tuberculosis (TB). Nephrotoxicity is a rare side effect of intermittent Rifampin use and even less commonly continued use. We report a case of Rifampin‐induced acute tubular necrosis and hemolysis in a patient with latent TB with a relevant literature review.Acute kidney injury with hemolysis due to Rifampin (intermittent or continuous use) is rare and mainly presents as acute tubular necrosis or acute interstitial nephritis. The mechanism of injury is probably autoimmune‐mediated, with a good recovery.

Cite

CITATION STYLE

APA

Ata, F., Magboul, H. M. B., Toba, H. A. A., Alfar, H., Al Bozom, A., Murshed, K., & Zahid, M. (2022). Rifampin‐induced acute kidney injury and hemolysis: A case report and literature review of a rare condition. Clinical Case Reports, 10(12). https://doi.org/10.1002/ccr3.6780

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free